N-Methyl-N-ethyltryptamine

N-Methyl-N-ethyltryptamine
Names
Preferred IUPAC name
N-Ethyl-2-(1H-indol-3-yl)-N-methylethan-1-amine
Identifiers
CAS Number
3D model (JSmol)
ChemSpider
PubChem CID
UNII
InChI
  • InChI=1S/C13H18N2/c1-3-15(2)9-8-11-10-14-13-7-5-4-6-12(11)13/h4-7,10,14H,3,8-9H2,1-2H3 checkY
    Key: MYEGVMLMDWYPOA-UHFFFAOYSA-N checkY
  • InChI=1/C13H18N2/c1-3-15(2)9-8-11-10-14-13-7-5-4-6-12(11)13/h4-7,10,14H,3,8-9H2,1-2H3
    Key: MYEGVMLMDWYPOA-UHFFFAOYAX
SMILES
  • c1cccc2c1c(c[nH]2)CCN(CC)C
Properties
Chemical formula
 C13H18N2
Molar mass 202.295 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

N-Methyl-N-ethyltryptamine (MET) is a psychedelic tryptamine. It is closely related to DMT and DET.[1][2] The Lysergamide counterpart of MET is ETH-LAD, an analogue of LSD first developed and characterized by Alexander Shulgin.

There is very little information on the human pharmacology or toxicity of MET. The freebase is believed to be active via vaporization at 15 mg.[3]

References

  1. ↑ Schifano F, Orsolini L, Papanti D, Corkery J. NPS: Medical Consequences Associated with Their Intake. Curr Top Behav Neurosci. 2017;32:351-380. doi:10.1007/7854_2016_15 PMID 27272067
  2. ↑ Halberstadt AL, Geyer MA. Effect of Hallucinogens on Unconditioned Behavior. Curr Top Behav Neurosci. 2018;36:159-199. doi:10.1007/7854_2016_466 PMID 28224459
  3. ↑ "That's okay, you're good" MET trip report - The Vaults of Erowid


This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.